REBECCA WHITE: Open Payments
NPI 1396311015 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 29 payments from 14 companies in 2025. Trend: 2023 $57 · 2024 $970 · 2025 $703
Food & beverage: $700Education: $3
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $230 |
| AKEBIA THERAPEUTICS INC | 4 | $106 |
| Calliditas Therapeutics US Inc. | 4 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| Travere Therapeutics, Inc. | 3 | $26 |
| Lilly USA, LLC | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Vifor Pharma, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: JYNARQUE, TARPEYO, Auryxia, Kerendia, JARDIANCE, KEVEYIS, Veltassa, Vafseo.
Industry payments across GA — which companies pay providers there.
